These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The prevention of chrysotherapy complications in patients with rheumatoid arthritis]. Berezhnitskiĭ MN; Ornat SIa; Aleksandruk DP Vrach Delo; 1989 Apr; (4):55-7. PubMed ID: 2756689 [TBL] [Abstract][Full Text] [Related]
9. Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Berglöf FE; Berglöf K; Walz DT J Rheumatol; 1978; 5(1):68-74. PubMed ID: 641915 [TBL] [Abstract][Full Text] [Related]
10. [The significance of gold serum level determinations during chrysotherapy in rheumatoid arthritis (author's transl)]. Bahous I; Müller W; Stojan B Med Klin; 1975 Sep; 70(38):1516-21. PubMed ID: 810649 [TBL] [Abstract][Full Text] [Related]
11. Chrysotherapy in rheumatoid arthritis. Myers AR Mod Treat; 1971 Nov; 8(4):761-8. PubMed ID: 4258496 [No Abstract] [Full Text] [Related]
12. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)]. D'eshougues JR; Delcambre B; Maquerlot M; Defrance D Lille Med; 1977; 22(7):430-8. PubMed ID: 412025 [No Abstract] [Full Text] [Related]
13. Chrysotherapy: pharmacological and clinical correlates. Lorber A; Simon TM; Leeb J; Carroll PE J Rheumatol; 1975 Dec; 2(4):401-10. PubMed ID: 1206672 [TBL] [Abstract][Full Text] [Related]
14. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents]. Menninger H; Burkhardt H Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333 [TBL] [Abstract][Full Text] [Related]
15. Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis. Rovenská E; Kapeller K; Rossmann P Czech Med; 1979; 2(3):125-33. PubMed ID: 535499 [TBL] [Abstract][Full Text] [Related]
16. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction. Stein HB; Ruedy J; Atkins CJ; Offer RC Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126 [TBL] [Abstract][Full Text] [Related]
17. [Ulcerative colitis caused by oral gold therapy in rheumatoid arthritis]. Bross-Bach U; Saal JG; Hartmann F; Müller CA; Waller HD Z Rheumatol; 1987; 46(4):201-4. PubMed ID: 3118590 [TBL] [Abstract][Full Text] [Related]
18. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J; Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of evolutive chronic polyarthritis with chrysotherapy. Reports. Conclusions. Summaries]. Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):669-79. PubMed ID: 5004879 [No Abstract] [Full Text] [Related]
20. [Significance of serum gold levels during chrysotherapy in chronic polyarthritis (proceedings)]. Bahous I; Müller W Z Rheumatol; 1976; 35 Suppl 4():suppl 395-400. PubMed ID: 983398 [No Abstract] [Full Text] [Related] [Next] [New Search]